April 2019
Volume 32, No. 4 |
|
|
|
|
|
| COVER STORY |
Cynthia A. Challener
Getting the science right helps biopharma startups overcome development and commercialization challenges.
read more
| DEVELOPMENT |
Feliza Mirasol
Drug makers continue to explore innovative ways to develop antibody-drug conjugates based on their unique potential to neutralize cancer cells.
read more
| FORMULATION |
Felicity Thomas
As biologics continue to push boundaries, the industry needs to take a holistic approach to formulation to ensure success.
read more
|
|
|
BioPharm International April Issue
|
advertisement
|
|
| BIOMANUFACTURING |
Felicity Thomas
To achieve further cost reductions in biosimilar manufacturing, a move away from traditional models is necessary.
read more
| DOWNSTREAM PROCESSING |
Amber Lowry
The latest advances in downstream processing include remote monitoring, membrane chromatography technology, single-use sensors, and new uses of data analytics.
read more
| MANUFACTURING |
Elizabeth Rivera, Dijana Hadziselimovic
Laboratory test methods evaluate cleaning agents and cleaning process design for removing resin residues from the surfaces of non-dedicated chromatography columns systems.
read more
| MANUFACTURING: LYOPHILIZATION |
Felicity Thomas
Technical advances in process understanding and control must be accompanied by a change in mindset.
read more
|
|
|
| ANALYTICS |
Ioscani Jiménez del Val
Close collaboration between academic and industrial groups is vital to ensuring glycosylation models are fit for deployment.
read more
| INTERNATIONAL REGULATIONS |
Felicity Thomas
Globally accepted products are becoming increasingly in demand, leading to more need for regulatory harmonization, particularly for biosimilars.
read more
| OUTSOURCING |
Feliza Mirasol
A look at the skill sets and training needed to tackle the increasing levels of automation in bioprocessing facilities.
read more
| INTELLECTUAL PROPERTY |
Agnes Shanley
While it may not be getting easier, biopharma patent protection is at least becoming more predictable.
read more
| FROM THE EDITOR |
Rita C. Peters
Promoting patient compliance with drug regimens extends beyond the formulation laboratory.
read more
| REGULATORY BEAT |
Jill Wechsler
FDA is moving to shift industry away from step-wise batch production.
read more
| ASK THE EXPERT |
Susan J. Schniepp
A robust customer complaint handling system is an integral part of a quality management system, says Susan Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.
read more
|
|
|
UPCOMING WEBCASTS
Characterizing CQAs of Biopharmaceutical Products: A Comprehensive Workflow Approach to Common Biopharmaceutical Tests
US and Europe: Wednesday, April 24, 2019 at 9am EDT | 2pm BST | 3pm CEST
US: Wednesday, April 24, 2019 at 2pm EDT | 1pm CDT | 11am PDT
Asia-Pacific: Thursday, April 25, 2019 at 8:30am IST | 11am CST | 12pm JST
Register Now
Approaches to Analyze and Understand 1–100 μm Particles/Aggregates in Biotherapeutics
Tuesday, April 23, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Direct Identification of Contaminant Particles on Lyophilization Cakes
Thursday, April 18, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Approaches to mAb Charge Variant Characterization using On-Line CEX-MS and Off-Line Analysis of CEX Purified Variants
Wednesday, April 17, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Meaningful Analytics Data for Quick Decision Making in Development of Viral Vector-Based Therapies
Wednesday, April 10, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
|
|
|
|
| EVENTS |
April 14–17, 2019
April 23–24, 2019
April 30–May 2, 2019
more events
|
|
|
|
|